Oryzon Genomics SA (XMAD:ORY)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ORY

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ORY

  • Market Cap€152.480m
  • SymbolXMAD:ORY
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINES0167733015

Company Profile

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics.

Latest ORY news

Currently there for this company. Visit our news hub for other news .